Amlodipine
Amlodipine Orion contains the active substance amlodipine, which belongs to a group of medicines called calcium antagonists.
Amlodipine Orion is used to treat high blood pressure (hypertension) or chest pain (angina pectoris) and its rare form, called Prinzmetal's angina.
In patients with high blood pressure, the medicine widens the blood vessels, making it easier for blood to flow through them. In patients with angina, Amlodipine Orion makes it easier for blood to reach the heart muscle, increasing the amount of oxygen supplied, which in turn prevents chest pain. This medicine does not immediately relieve chest pain caused by angina.
Before taking Amlodipine Orion, the patient should discuss it with their doctor or pharmacist.
The patient should inform their doctor if they have or have had any of the following conditions:
No studies have been conducted on the use of amlodipine in children under 6 years of age. Amlodipine Orion can be used in children and adolescents from 6 to 17 years of age only for the treatment of high blood pressure (see section 3).
Doses of 2.5 mg cannot be obtained with Amlodipine Orion 5 mg tablets, as these tablets are manufactured in a way that prevents them from being broken in half. To obtain a dose of 2.5 mg, other amlodipine-containing medicines should be used.
It is essential to take the tablets continuously. Do not wait until all the tablets have been used before visiting the doctor.
The patient should tell their doctor or pharmacist about all the medicines they are taking or have recently taken, as well as any medicines they plan to take.
Amlodipine Orion may interact with other medicines or other medicines may interact with Amlodipine Orion. These include:
Amlodipine Orion may lower blood pressure more if the patient is taking other antihypertensive medicines.
While taking Amlodipine Orion, the patient should not drink grapefruit juice or eat grapefruits, as they may increase the levels of the active substance, amlodipine, in the blood, which may cause unpredictable enhancement of the blood pressure-lowering effect of Amlodipine Orion.
There is no data on the safety of amlodipine during pregnancy. If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Breastfeeding
It has been shown that small amounts of amlodipine pass into human milk. If the patient is breastfeeding or plans to breastfeed, they should consult their doctor before taking Amlodipine Orion.
Amlodipine Orion may affect the patient's ability to drive or use machines.
If the tablets cause nausea, dizziness, fatigue, or headache, the patient should not drive or use machines and should contact their doctor immediately.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as prescribed by the doctor or pharmacist. If the patient has any doubts, they should ask their doctor or pharmacist.
The recommended initial dose is 5 mg of amlodipine once a day. The doctor may increase the dose to 10 mg once a day.
This medicine can be taken before or after meals and drinks. The patient should take the medicine every day at the same time, with a glass of water.
In children and adolescents (6-17 years), the recommended initial dose is 2.5 mg once a day. The maximum recommended dose is 5 mg once a day. Doses of 2.5 mg cannot be obtained with Amlodipine Orion 5 mg tablets, as these tablets are manufactured in a way that prevents them from being broken in half. To obtain a dose of 2.5 mg, other amlodipine-containing medicines should be used.
It is essential to take the tablets continuously. Do not wait until all the tablets have been used before visiting the doctor.
Taking too many tablets may cause a significant drop in blood pressure. The patient may experience dizziness, a feeling of "emptiness" in the head, fainting, or weakness. If the drop in blood pressure is severe, it may lead to shock.
Even 24-48 hours after taking the medicine, the patient may experience shortness of breath caused by excess fluid accumulating in the lungs (pulmonary edema).
The skin may become cool and moist, and the patient may lose consciousness. If the patient has taken too many Amlodipine Orion tablets, they should contact their doctor or go to the emergency department of the nearest hospital immediately.
If the patient forgets to take a tablet, they should skip it. They should take the next dose at the usual time. Do not take a double dose to make up for the missed dose.
The doctor will tell the patient how long to take the medicine. If the patient stops taking the medicine before the doctor advises, their condition may worsen.
If the patient has any further questions about taking this medicine, they should ask their doctor or pharmacist.
Like all medicines, Amlodipine Orion can cause side effects, although not everybody gets them.
If the patient experiences any of the following side effects after taking the medicine, they should immediatelycontact their doctor:
The following side effects have been reported. If any of these side effects are troublesome for the patient or last for more than a week, they should contact their doctor.
The following side effects have been reported. If any of these side effects are troublesome for the patient or last for more than a week, they should contact their doctor.
Other side effects that have been reported are listed below. If any of these side effects worsen or if the patient experiences any side effects not listed in this leaflet, they should tell their doctor or pharmacist.
Very rare: may affect up to 1 in 10,000 people
If the patient experiences any side effects, including any not listed in this leaflet, they should tell their doctor or pharmacist.
Side effects can be reported directly to the
Department for Monitoring of Adverse Reactions to Medicinal Products
National Institute of Medicines
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301, Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storage of the medicinal product.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP:" or "EXP:". The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
5 mg: White or almost white, flat, uncoated tablets with a biconvex shape, with beveled edges, with the inscription "C" on one side and "58" on the other. The tablet dimensions are 7.9 mm x 5.6 mm.
10 mg: White or almost white, flat, round, uncoated tablets with beveled edges, with the inscription "C" on one side and "59" on the other. The tablet diameter is 9.5 mm.
PVC/PVDC/Aluminum blister pack in a cardboard box.
Pack sizes: 30 tablets
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information about this medicine, the patient should contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Date of last revision of the leaflet:21.06.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.